Foot-and-Mouth Disease clinical trials
The registry lists 7 studies for Foot-and-Mouth Disease across 5 countries. 2 are recruiting or about to start. 4 of them are mainly about Foot-and-Mouth Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.
Get an email when these change. Save the Foot-and-Mouth Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Enimmune Corporation (2) · Cairo University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Tanta University (1) · Mashhad University of Medical Sciences (1)
What is being tested here
Drugs under test in Foot-and-Mouth Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Rebamipide | 1 | 0 | 1 |
| Enterovirus 71 vaccine | 0 | 1 | 1 |
| Bee Venoms | 0 | 0 | 1 |
| EV71 | 0 | 0 | 1 |
| Coenzyme Q10 | 0 | 0 | 1 |
| Prednisolone | 0 | 0 | 1 |
| Colchicine | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Apr 2027Evaluation of Topical Rebamipide Versus Topical Betamethasone for Treatment of Oral Aphthous Ulcers · Cairo University
Who these studies take
Of the 2 Foot-and-Mouth Disease studies recruiting now, 0 (0%) set no upper age limit and 1 (50%) stop at 75 or younger. 1 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (50%) | 1 (50%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 2 (100%) | 2 (100%) |
| 75 | 1 (50%) | 1 (50%) |
| 85 | 1 (50%) | 1 (50%) |
Across all 7 studies, recruiting or not: 71% stop at 75 or younger and 57% at 65; 86% take children; 0% are for women only and 0% for men only; 57% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. search them.
- Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related DisordersRecruitingNCT076831041 country
- Evaluation of Topical Rebamipide Versus Topical Betamethasone for Treatment of Oral Aphthous UlcersRecruitingNCT06084624Phase 21 country
- A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and ChildrenCompletedNCT05099029Phase 32 countries
- Apitoxin Versus Soft Laser for Management of Aphthous Ulceration.CompletedNCT07135609Not applicable1 country
- A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric SubjectsCompletedNCT03268083Phase 21 country
- Clinical Evaluation of Topical Coenzyme Q10 in Management of Oral Aphthous UlcerStatus unknownNCT03213769Not applicable
- Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral AphthaeStatus unknownNCT00723268Phase 21 country